Anticoagulation, CHA2DS2VASc Score, and Thromboembolic Risk of Cardioversion of Acute Atrial Fibrillation (from the FinCV Study).

---

Autoria(s): Grönberg, Toni

Data(s)	07/04/2016 07/04/2016 07/04/2016
Identificador	http://www.doria.fi/handle/10024/122001
Idioma(s)	fi